Title : Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).

Pub. Date : 2013

PMID : 24098467






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Baseline characteristics in both groups were similar, but after 12 weeks of treatment, LDL-C levels were significantly lower: pitavastatin group = -35.0 +- 14.1% and atorvastatin group = -38.4 +- 12.8% (both: p < 0.001). pitavastatin component of oligomeric golgi complex 2 Homo sapiens
2 CONCLUSION: Both pitavastatin (2 mg/day) and atorvastatin (10 mg/day) were well tolerated, lowered LDL-C, and improved the lipid profile to a comparable degree in high-risk Taiwanese patients with hypercholesterolemia. pitavastatin component of oligomeric golgi complex 2 Homo sapiens